Psychiatry Research
Volume 136, Issue 2 , Pages 83-91 , 15 September 2005

No association found between 158 Val/Met polymorphism of the COMT gene and schizophrenia with minor physical anomalies

  • Eun-Jeong Joo

      Affiliations

    • Department of Psychiatry, Eulji University School of Medicine, Daegeon, South Korea
    • ,
  • Seong-Hoon Jeong

      Affiliations

    • Department of Psychiatry, Dongguk University College of Medicine, Gyeongju, South Korea
    • ,
  • Yong-Min Ahn

      Affiliations

    • Department of Psychiatry and Behavioral Science and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-744, South Korea
    • ,
  • Kyu-Young Lee

      Affiliations

    • Department of Psychiatry, Seoul National University Hospital, Seoul, South Korea
    • ,
  • Se Chang Yoon

      Affiliations

    • Department of Psychiatry, Sungkyunkwan University School of Medicine, Seoul, South Korea
    • ,
  • Eui-Joong Kim

      Affiliations

    • Department of Psychiatry, Eulji University School of Medicine, Daegeon, South Korea
    • ,
  • Seon-Uk Kim

      Affiliations

    • Department of Psychiatry, Eulji University School of Medicine, Daegeon, South Korea
    • ,
  • Soo-Churl Cho

      Affiliations

    • Department of Psychiatry and Behavioral Science and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-744, South Korea
    • ,
  • Yong Sik Kim

      Affiliations

    • Department of Psychiatry and Behavioral Science and Institute of Human Behavioral Medicine, Seoul National University College of Medicine, 28 Yongon-Dong Chongno-Gu, Seoul, 110-744, South Korea
    • Corresponding Author InformationCorresponding author. Tel.: +82 2 2072 2204; fax: +82 2 744 7241.

Received 19 June 2004 ,Revised 22 November 2004 ,Accepted 16 December 2004.

References 

  1. Arinami T, Ohtsuki T, Takase K, Shimizu H, Yoshikawa T, Horigome H, et al. Screening for 22q11 deletions in a schizophrenia population. Schizophrenia Research. 2001;52:167–170
  2. Bassett AS, Chow EWC. 22q11 Deletion syndrome: a genetic subtype of schizophrenia. Biological Psychiatry. 1999;46:882–891
  3. Chen CH, Lee YR, Chung MY, Wei FC, Koong FJ, Shaw CK, et al. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. American Journal of Psychiatry. 1999;156:1273–1275
  4. de Chaldee M, Corbex M, Campion D, Jay M, Samolyk D, Petit M, et al. No evidence for linkage between COMT and schizophrenia in a French population. Psychiatry Research. 2001;102:87–90
  5. Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, et al. Effect of COMT Val108/158Met genotype on frontal lobe function and risk for schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 2001;12:6917–6922
  6. Fan JB, Chen WY, Tang JX, Li S, Gu NF, Feng GY, et al. Family-based association studies of COMT gene polymorphisms and schizophrenia in the Chinese population. Molecular Psychiatry. 2002;7:446–447
  7. Fan J-B, Ma J, Zhang C-S, Tang J-X, Gu N-F, Feng G-Y, et al. A family-based association study of T1945C polymorphism in the proline dehydrogenase gene and schizophrenia in the Chinese population. Neuroscience Letters. 2003;338:252–254
  8. Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF, et al. Association of the G1947A COMT(Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biological Psychiatry. 2003;54:40–48
  9. Glatt SJ, Faraone SV, Tsuang MT. Association between a functional catechol O-methyltransferase gene polymorphism and schizophrenia: meta-analysis of case-control and family-based studies. American Journal of Psychiatry. 2003;160:469–476
  10. Gothelf D, Frisch A, Munitz H, Rockah R, Aviram A, Mozes T, et al. Velocardiofacial manifestations and microdeletions in schizophrenic inpatients. American Journal of Psychiatry. 1997;72:455–461
  11. Gourion D, Goldberger C, Bourdel M-C, Baylé FJ, Lôo H, Krebs M-O. Minor physical anomalies in patients with schizophrenia and their parents: prevalence and pattern of craniofacial abnormalities. Psychiatry Research. 2004;125:21–28
  12. Gourion D, Goldberger C, Olié J-P, Krebs M-O. Neurological and morphological anomalies and the genetic liability to schizophrenia: a composite phenotype. Schizophrenia Research. 2004;67:23–31
  13. Green MF, Satz P, Gaier DJ, Ganzell S, Kharabi F. Minor physical anomalies in schizophrenia. Schizophrenia Bulletin. 1989;15:91–99
  14. Griffiths TD, Sigmundsson T, Takei N, Frangou S, Birkett PB, Sharma T, et al. Minor physical anomalies in familial and sporadic schizophrenia: the Maudsley family study. Journal of Neurology, Neurosurgery and Psychiatry. 1998;64:56–60
  15. Guy JD, Majorski LV, Wallace CJ, Guy MP. The incidence of minor physical anomalies in adult male schizophrenics. Schizophrenia Bulletin. 1983;9:571–582
  16. Herken H, Erdal ME. Catechol-O-methyltransferase gene polymorphism in schizophrenia: evidence for association between symptomatology and prognosis. Psychiatric Genetics. 2001;11:105–109
  17. Hyman SE, Fenton WS. Medicine. What are the right targets for psychopharmacology?. Science. 2003;299:350–351
  18. Inada T, Nakamura A, Iijima Y. Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. American Journal of Medical Genetics. 2003;1:35–39
  19. Innocenti GM, Ansermet F, Parnas J. Schizophrenia, neurodevelopment and corpus callosum. Molecular Psychiatry. 2003;8:261–274
  20. Ismail B, Cantor-Graae E, McNeil TF. Minor physical anomalies in schizophrenic patients and their siblings. American Journal of Psychiatry. 1998;155:1695–1702
  21. Jones G, Zammit S, Norton N, Hamshere ML, Jones SJ, Milham C, et al. Aggressive behavior in patients with schizophrenia is associated with catechol-O-methyltransferase genotype. British Journal of Psychiatry. 2001;179:351–355
  22. Joo EJ, Yi JS, Hong KS, Jung HY, Shin CJ, Kang UG, et al. Minor physical anomalies, obstetric complications and family history of schizophrenia. Journal of the Korean Neuropsychiatric Association. 1996;35:778–789(in Korean)
  23. Joo EJ, Jeong SH, Maeng SJ, Yoon SC, Kim JH, Kim CE, et al. Minor physical anomalies in patients with schizophrenia. Journal of the Korean Society of Biological Psychiatry. 2002;9:140–151(in Korean)
  24. Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, Borrow J, et al. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proceedings of the National Academy of Sciences of the United States of America. 1995;92:7612–7616
  25. Kim MS, Chee IS, Lee SW, Shin SC, Lee YH. Catechol-O-methyltransferase gene polymorphism (Valine/Methionine) associated neither with schizophrenia nor with bipolar disorders in a Korean population. Journal of the Korean Neuropsychiatric Association. 2001;40:510–519(in Korean)
  26. Korea Research Institute of Standards . In: Fourth Report on Standard Body Measurement of Korean Population. 1997;(in Korean)
  27. Kremer I, Pinto M, Murad I, Muhaheed M, Bannoura I, Muller DJ, et al. Family-based and case-control study of catechol-O-methyltransferase in schizophrenia among Palestinian Arabs. American Journal of Medical Genetics. 2003;15:35–39
  28. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics. 1996;6:243–250
  29. Lane A, Kinsella A, Murphy P, Byrne M, Keenan J, Colgan K, et al. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychological Medicine. 1997;27:1155–1164
  30. Lawrie SM, Byrne M, Miller P, Hodges A, Clafferty RA, Cunningham , et al. Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. British Journal of Psychiatry. 2001;178:524–530
  31. Lencz T, Cornblatt B, Bilder RM. Neurodevelopmental models of schizophrenia: pathophysiologic synthesis and directions for intervention research. Psychopharmacology Bulletin. 2001;35(1):95–125
  32. Li T, Ball D, Zhao J, Murray RM, Liu X, Sham PC, et al. Family-based linkage disequilibrium mapping using SNP marker haplotypes: application to a potential locus for schizophrenia at chromosome 22q11. Molecular Psychiatry. 2000;5:77–84
  33. Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC. Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology. 2001;43:11–14
  34. Makridakis NM, Reichardt JK. Multiplex automated primer extension analyses: simultaneous genotyping of several polymorphisms. BioTechniques. 2001;31:1374–1380
  35. Malhotra AK, Kestler LJ, Mazzanti C, Bates JA, Goldberg T, Goldman D. A functional polymorphism in the COMT gene and performance on a test of prefrontal function. American Journal of Psychiatry. 2002;159:652–654
  36. Murphy KC. Schizophrenia and velo-cardio-facial syndrome. Lancet. 1997;359(9304):426–430
  37. Murphy KC, Owen MJ. Velo-cardio-facial syndrome: a model for understanding the genetics and pathogenesis of schizophrenia. British Journal of Psychiatry. 2001;179:397–402
  38. Murphy KC, Jones RG, Griffiths E, Thompson PW, Owen MJ. Chromosome 22q11 deletions. An under-recognised cause of idiopathic learning disability. British Journal of Psychiatry. 1998;172:180–183
  39. Murphy KC, Jones LA, Owen MJ. High rates of schizophrenia in adults with velo-cardio-facial syndrome. Archives of General Psychiatry. 1999;56:940–945
  40. Nicolson R, Giedd JN, Lenane M, Hamburger S, Singaracharlu S, Bedwell J, et al. Clinical and neurobiological correlates of cytogenetic abnormalities in childhood-onset schizophrenia. American Journal of Psychiatry. 1999;156:1575–1579
  41. Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, Mita T, et al. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neuroscience Letters. 1998;243:109–112
  42. Ohtsuki T, Tanaka S, Ishiguro H, Noguchi E, Arinami T, Tanabe E, et al. Failure to find association between PRODH deletion and schizophrenia. Schizophrenia Research. 2004;67:111–113
  43. Palmatier MA, Kang AM, Kidd KK. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biological Psychiatry. 1999;46:557–567
  44. Park DM, Song JW, Han KH, Kang JS. Anthropometry of normal Korean eyelids. Journal Korean Society of Plastic Reconstructive Surgery. 1990;17:822–835(in Korean)
  45. Park T-W, Yoon K-S, Kim J-H, Park W-Y, Hirvonen A, Kang D. Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophrenia. European Neuropsychopharmacology. 2002;12:299–303
  46. Rybakowski JK, Borkowska A, Czerski PM, Hauser J. Eye movement disturbances in schizophrenia and a polymorphism of the catechol-O-methyltransferase gene. Psychiatry Research. 2002;113:49–57
  47. Schiffman J, Ekstrom M, LaBrie J, Schulsinger F, Sorensen H, Mednick S. Minor physical anomalies and schizophrenia spectrum disorders: a prospective investigation. American Journal of Psychiatry. 2002;159:238–243
  48. Semwal P, Prasad S, Bhatia T, Deshpande SN, Wood J, Nimgaonkar VL, et al. Family-based association studies of monoaminergic gene polymorphisms among North Indians with schizophrenia. Molecular Psychiatry. 2001;6:220–224
  49. Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, Weizman A, et al. A highly significant association between a COMT haplotype and schizophrenia. American Journal of Human Genetics. 2002;71:1296–1302
  50. Shprintzen RJ, Goldberg R, Golding-Kushner KJ, Marion RW. Late-onset psychosis in the velo-cardio-facial syndrome. American Journal of Medical Genetics. 1992;42:141–142
  51. Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM. Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. American Journal of Medical Genetics. 2003;1:29–34
  52. Thomas JA, Graham JMJr. Chromosome 22q11 deletion syndrome: an update and review for the primary pediatrician. Clinical Pediatrics. 1997;36:253–266
  53. Tsai SJ, Yu Y, Chen TJ, Chen JY, Liou YJ, Chen MC, et al. Association study of a functional catechol-O-methyltransferase gene polymorphism and cognitive function in healthy females. Neuroscience Letters. 2003;338:123–126
  54. Waldrop MF, Pedersen FA, Bell RQ. Minor physical anomalies and behavior in preschool children. Child Development. 1968;39:391–400
  55. Weinberger DR. From neuropathology to neurodevelopment. Lancet. 1995;346(8974):552–557
  56. Williams HJ, Williams N, Spurlock G, Norton N, Ivanov D, McCreadie RG, et al. Association between PRODH and schizophrenia is not confirmed. Molecular Psychiatry. 2003;8:644–645
  57. Yan W, Jacobsen LK, Krasnewich DM, Guan XY, Lenane MC, Paul SP, et al. Chromosome 22q11.2 interstitial deletions among childhood-onset schizophrenics and “multidimensionally impaired”. American Journal of Medical Genetics. 1998;81:41–43

PII: S0165-1781(05)00165-4

doi: 10.1016/j.psychres.2004.12.011

Psychiatry Research
Volume 136, Issue 2 , Pages 83-91 , 15 September 2005

Article Tools